This product is a kind of small molecular ribonucleic acid, which is used to transport amino acids specifically in protein biosynthesis and ensure the accurate transmission of genetic information from nucleic acid to protein.

Milbemycin A4 Oxime

CAS:93074-04-5

Molecular Formula:C32H45NO7

Alias

More Information

5-Ketomilbemycin A4 5-Oxime

Brief Introduction

This product is a microbial metabolite.

1-Kestoheptaose

CAS:62512-20-3

Molecular Formula:C42H72O36

Alias

More Information

2-O-[2-O-[2-O-[2-O-(2-O-Alpha-D-Glucopyranosyl-1-Deoxy-Beta-D-Fructofuranose-1-Yl)-1-Deoxy-Beta-D-Fructofuranose-1-Yl]-1-Deoxy-Beta-D-Fructofuranose-1-Yl]-1-Deoxy-Beta-D-Fructofuranose-1-Yl]-1-Deoxy-Beta-D-Fructofuranose-1-Yl Beta-D-Fructofuranoside

Brief Introduction

This product is mainly used as pharmaceutical and chemical intermediates.

83534-39-8

CAS:83534-39-8

Alias

More Information

Pngase F; N-Glycosidase F; Native Almonds Glycopeptidase A; Pngase A; Glycopeptide N-Glycosidase; N-Oligosaccharide Glycopeptidase; N-Glycanase; Glycopeptidase; Jack-bean Glycopeptidase; Peptide-N4-(N-Acetyl-|A-Glucosaminyl)Asparagine Amidase; Pngase

Brief Introduction

N-glycosidase F (PNGase F) is an amidohydrolase, cloned from the Peaceful Space Station Elizabeth and recombinantly expressed in E. coli E. coli, that cleaves asparagine-linked high-mannose, hybrid and complex oligosaccharide glycoproteins. The cleavage site of PNGase F is the amide bond between N-acetylglucosamine (GlcNAc) and asparagine residues on the inner side of the glycoprotein, and at the same time, the aspartyl on the protein after enzymatic hydrolysis is converted to aspartic acid. This product is often used for complete deglycosylation of antibodies and related proteins.

Aducanumab

CAS:1384260-65-4

Alias

More Information

Aducanumab (USAN); D10541; Aducanumab (Genetical Recombination) (JAN); BIIB037; BIIB-037

Brief Introduction

Aducanumab is a human monoclonal antibody that is being studied for the treatment of Alzheimer's disease (AD). It is being developed by Biogen Inc., which licensed the drug candidate from Neurimmune, its discoverer.The antibody targets aggregated forms of β-amyloid (Aβ) in the hopes of reducing its buildup.

1
···
24
25
26
27
28
29
30
31
32

Inquiry (

/ 10

)

Clear All